Business
Molbio Diagnostics IPO GMP today: Should you subscribe? Check listing gain potential, valuation and risks
Molbio Diagnostics IPO entered Day 2 with a GMP of Rs 127, indicating a potential 15.7% listing gain. Here's the subscription status, valuation, risks and analyst views.
5 min read




